Sucampo Pharmaceuticals, Inc. Class A
(NASDAQ : SCMP)

( )
SCMP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
3.40%140.750.6%$720.84m
ABBVAbbVie, Inc.
1.22%92.152.1%$564.98m
PFEPfizer Inc.
0.63%36.210.8%$555.92m
MRKMerck & Co., Inc.
-0.19%63.220.6%$455.86m
BMYBristol-Myers Squibb Company
0.83%64.181.4%$328.41m
LLYEli Lilly and Company
0.08%86.021.0%$262.34m
AZNAstraZeneca PLC Sponsored ADR
0.38%34.781.3%$156.16m
GSKGlaxoSmithKline plc Sponsored ADR
-0.07%40.830.2%$153.89m
NVSNovartis AG Sponsored ADR
-0.04%86.340.2%$133.35m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.04%49.300.1%$106.26m
SNYSanofi Sponsored ADR
-0.16%49.550.2%$55.90m
LCILannett Company, Inc.
-2.32%23.1538.6%$20.62m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.24%6.402.2%$6.24m
SCMPSucampo Pharmaceuticals, Inc. Class A
3.50%10.3514.4%$5.38m
EPIXESSA Pharma Inc
-2.20%0.290.0%$0.03m

Company Profile

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. It operates through the following geographic segments: Asia, the Americas, and Europe. It offers Lubiprostone, which treats chronic constipation, chronic idiopathic constipation in adults, irritable bowel syndrome with constipation in adult women, and opiod-induced constipation in adults with chronic non-cancer pain. The company was founded by Dr. Ryuji Ueno and Dr. Sachiko Kuno on December 5, 1996 and is headquartered in Rockville, MD.